Or­bimed part­ner in search of a cure for Parkin­son’s launch­es new gene ther­a­py play­er

Jonathan Sil­ver­stein is ac­tive­ly look­ing for a biotech mir­a­cle.

The Or­bimed part­ner formed a non­prof­it group called the Sil­ver­stein Foun­da­tion af­ter he was di­ag­nosed with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.